92% Recoveries Recorded
The SECURE-SCD Registry has reported that as of July 2, 2020, 235 persons with sickle cell have been reported as having caught the Coronavirus. 16 fatalities have been recorded.
BREAKDOWN
SCD Type: SS (71.35%), SC (19.88%), SBeta zero Thal (4.68%). Sbeta Thal (4.09%) of the total affected.
Age: The average age of those affected is 28.31 with a standard deviation of 15.06
Sex: More females (55.56%) than males (43.11%) have been affected, with the overwhelming majority being African Americans
Presenting Symptoms: Symptoms SCD patients affected by the Coronavirus presented with include Pain (62.21%), and Pneumonia (30.81%), some presented with a combination of Pain and Pnuemonia. Other less significant symptoms include kidney failure, splenic sequestration, pulmonary hypertension, arrythmias, aplastic crises and stroke.
Treatment: Sickle cell patients with the Coronavirus were treated with
- AZYTHROMYCIN
- HYDROXYCHLOROQUINE
- CORTICOSTEROIDS
- HEPARIN
- REMDESIVIR
- TOCILIZUMAB
Treatment Interventions:
- BLOOD TRANSFUSION
- VENTILATION
- INTENSIVE CARE
- HOSPITALIZATION
Ethnicity: Black/African Americans are by far the most affected. Whites, Asians, southern Europeans, Hispanics and others occupy just a tiny fraction of the affected population.
Countries Affected: Brazil, USA, Canada, Greece, Swizerland, Oman (Middle East)
Fatalities: 16 SCD patients affected with COVID-19 have died.
Africa
No known infections or fatalities recorded so far, a ‘miracle’ for a continent ill-prepared for such medical emergencies.
More about SECURE-SCD Registry
You May Also Like:
CORONAVIRUS: SICKLE CELL WARRIOR NORA MOLONGWE DEFEATS COVID-19